The Future of Pharma

  Measuring innovation: bringing great medicines to patients

                                                                         Follow us:      

Our next panel event is being held during BIO International, San Francisco, 2016

If you would like to be on the panel or join the audience, please send your request to

Pharmaceutical and biotech giants – Janssen, Otsuka and Teva – join IDEA Pharma in launching the first in a series of panel discussion sessions, called The Future of Pharma, at the annual J. P. Morgan Healthcare Conference, San Francisco. 

Tackling the multi-dimensional topic of innovation within the industry, understanding what it is, how it can be measured and how to better bring great medicines to patients, the company is joined by an esteemed panel, comprising Otsuka America Pharmaceutical Inc.’s President and COO, Bob Oliver; Janssen’s Global Head of R&D, Dr William N. Hait and Teva’s President of Global R&D and Chief Scientific Officer, Dr Michael Hayden.

IDEA unveils a new index – aptly named the IDEA Index - that rewards the most innovative pharma companies selected from the whole of pharma and biotech.